Bonum Therapeutics, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Bonum Therapeutics, Inc. - overview
Established
2021
Location
Seattle, WA, US
Primary Industry
Biotechnology
About
Based in Seattle, US, and founded in 2021, Bonum Therapeutics, Inc. is a biotechnology company developing protein-based drugs that can sense and respond to their local environment. In December 2021, Bonum Therapeutics, Inc. raised USD 1.
19 million in Angel investment from individual investors. Bonum Therapeutics develops protein-based drugs with regulated, and context-dependent activity with the capability of sensing their local environment and responding accordingly by changing to active form from inactive.
Current Investors
RiverVest Ventures Partners, Vivo Capital, Roche Venture Fund
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Oncology/Cancer Treatment
Website
www.bonumtx.com
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.